Book a Cardiologist near me

Dr Arul Baradi is an Interventional Cardiologist with appointments at the Alfred, Epworth Richmond, and St Vincent’s Private Hospitals. He consults at Victoria Heart in Melbourne and several locations regionally. Arul’s clinical interests are the prevention, diagnosis and treatment of coronary and structural heart disease. Arul has recently returned from the United Kingdom after completing a two-year fellowship in complex coronary intervention at the Royal Papworth Hospital (affiliated with the University of Cambridge and the United Kingdom’s leading cardiac specialty hospital) and a one-year fellowship in adult structural cardiac intervention at the Royal Sussex County Hospital under Professor David Hildick-Smith (current president of the British Cardiac Intervention Society). Prior to this, he completed medical school at the University of Auckland, New Zealand, and following internship and junior doctor years in Auckland moved to Melbourne where he completed physician and cardiology specialty training. Arul maintains an active role in research and teaching. He is a research fellow at the Cardiovascular Epidemiology Unit, the University of Cambridge, and a doctoral researcher at the University of Melbourne.

Practice Profile Description

Practice Profile Description

Dr Louise Segan is a consultant cardiologist and clinical electrophysiologist at St Vincent’s Private Hospital. Dr Segan specialises in arrhythmia management including ablation procedures and cardiac device management including pacemaker and defibrillator implantation, battery replacement and device monitoring. She is completing a full-time PhD in cardiac electrophysiology through the Baker Heart and Diabetes Institute and the University of Melbourne. Her research focuses on optimising outcomes in patients with atrial fibrillation (AF) and heart failure well as focusing on improving recognition of the important role of lifestyle modification in AF management. Dr Segan coordinated two ANZCTR registered clinical trials in AF and heart failure. The first, CAMERA-MRI II randomised study of early catheter ablation versus medical rate control in AF and HF with CMR-detected myocardial fibrosis, began recruitment in late 2020 and the results were recently presented as a Late Breaking Clinical Trial at ESC 2024 in London. The second study, the WITHDRAW-AF randomised study, explores the safety and feasibility of staged withdrawal of heart failure therapies in patients with rhythm-controlled AF and recovered AF mediated cardiomyopathy.